Suits Against Insulin Pricing Are Driven By Rebate Addiction
U.S. states, cities and counties are increasingly filing lawsuits against insulin manufacturers and pharmacy benefit managers over the issue of insulin pricing.[1]...To view the full article, register now.
Already a subscriber? Click here to view full article